Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|March 1, 1994
Osteoarthritis pain assessment in family practiceG H de Bock, H W van Marwijk, A A Kaptein, et al.
Tijdschrift Voor Gerontologie En Geriatrie|May 1, 1994
[Body weight of elderly patients on admission to a nursing home]A M Berkhout, H J Cools, J D Mulder
Tijdschrift Voor Gerontologie En Geriatrie|October 1, 1989
[Measurement or estimation of body length in older nursing home patients]A M Berkhout, H J Cools, J D Mulder
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 13, 2016
Cost-effectiveness of a carcinoembryonic antigen (CEA) based follow-up programme for colorectal cancer (the CEA Watch trial)C J Verberne, T Wiggers, I Grossmann, et al.
JPRAS Open|May 19, 2020
Satisfaction with cosmetic outcomes of breast reconstruction: Investigations into the correlation between the patients' Breast-Q outcome and the judgment of panelsY Eltahir, E Bosma, N Teixeira, et al.
European Radiology|May 24, 2006
The clinical value of a negative multi-detector computed tomographic angiography in patients suspected of coronary artery disease: A meta-analysisH J van der Zaag-Loonen, R Dikkers, G H de Bock, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 4, 2013
Changing patterns of recurrent disease in colorectal cancerI Grossmann, P M Doornbos, J M Klaase, et al.
Family Practice|October 26, 1999
GPs' management of women seeking help for familial breast cancerG H de Bock, T P Vliet Vlieland, M Hakkeling, et al.
British Journal of Cancer|June 2, 2011
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysisM J M Gooden, G H de Bock, N Leffers, et al.
Bone Marrow Transplantation|August 24, 2010
Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphomaW J Plattel, H C Kluin-Nelemans, G H de Bock, et al.
Pageof 19